Caricamento...
Validating Endpoints for Therapeutic Trials in Fecal Incontinence
BACKGROUND: A 50% or greater reduction in the frequency of fecal incontinence (FI) recorded with daily bowel diaries is the primary endpoint in clinical trials of FI. Whether this difference is clinically important is unknown. The relationship between FI symptoms recorded with daily and weekly instr...
Salvato in:
| Pubblicato in: | Neurogastroenterol Motil |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4956545/ https://ncbi.nlm.nih.gov/pubmed/26948292 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/nmo.12809 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|